A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma
Clinical trial NCT05043922 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05043922
- Sponsor
- Haihe Biopharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2024-07-31
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.